Journal
NATURE REVIEWS CANCER
Volume 16, Issue 8, Pages 494-507Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc.2016.63
Keywords
-
Categories
Funding
- US National Institutes of Health [R01 CA172398, R01 CA177319, R01 CA155743, R01 CA129382, R01 CA120196]
Ask authors/readers for more resources
T cell acute lymphoblastic leukaemia (T-ALL) is an aggressive haematological malignancy derived from early T cell progenitors. In recent years genomic and transcriptomic studies have uncovered major oncogenic and tumour suppressor pathways involved in T-ALL transformation and identified distinct biological groups associated with prognosis. An increased understanding of T-ALL biology has already translated into new prognostic biomarkers and improved animal models of leukaemia and has opened opportunities for the development of targeted therapies for the treatment of this disease. In this Review we examine our current understanding of the molecular mechanisms of T-ALL and recent developments in the translation of these results to the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available